The clinical presentation of restenosis after bare metal stent implantation: behind a facade of benignity

Int J Cardiol. 2009 Jul 10;135(3):401-3. doi: 10.1016/j.ijcard.2008.01.056. Epub 2008 Jun 20.

Abstract

Contrary to common belief, bare metal in-stent restenosis (ISR) seems to be not a benign clinical entity. Thus,we believed that continued efforts are warranted to prevent bare metal ISR, including aggressive use of drug-eluting stent (DES) to decrease the incidence of acute coronary syndromes. However, despite improved outcomes with DES, bare metal stent (BMS) will continue to play a role for both clinical and economic reasons and we feel that there is still a future for BMS.

Publication types

  • Comment
  • Letter

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects*
  • Coronary Restenosis / diagnosis*
  • Coronary Restenosis / etiology*
  • Humans
  • Stents / adverse effects*
  • Treatment Outcome